View Older Stories

Jul 16, 2026 06:39AM Guggenheim Reiterates Buy Rating on Merck (MRK)

Jul 13, 2026 07:58AM Merck (MRK) PT Raised to $142 at BMO Capital

Jul 13, 2026 06:53AM Merck (MRK) PT Raised to $145 at Guggenheim

Jul 8, 2026 06:08AM Merck (MRK) PT Raised to $113 at Morgan Stanley

Jun 30, 2026 07:20AM Merck (MRK) PT Raised to $155 at Scotiabank

Jun 30, 2026 06:02AM U.S. House committee opens investigation into Merck, AbbVie China drug trials - Reuters

Jun 30, 2026 05:23AM Merck (MRK) PT Raised to $141 at BofA Securities

Jun 29, 2026 06:45AM Merck reaches deal to expand HIV drug access via ADAP programs

Jun 17, 2026 11:15AM Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Jun 15, 2026 06:08AM German government to drop variable drug discounting plans - Reuters

Jun 2, 2026 07:23AM Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald

Jun 2, 2026 06:48AM Guggenheim Reiterates Buy Rating on Merck (MRK)

Jun 1, 2026 08:01AM Moderna and Merck report sustained melanoma treatment benefits at 5 years

Jun 1, 2026 08:00AM Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASC

May 29, 2026 06:49AM FDA grants breakthrough therapy designation to Merck's KRAS G12C inhibitor

May 26, 2026 01:28PM Merck (MRK) Declares $0.85 Quarterly Dividend; 2.8% Yield

May 22, 2026 09:54AM China holds roundtable with over 50 foreign pharmaceutical firms

May 22, 2026 09:25AM China Commerce Ministry holding meeting with foreign pharma companies including Lilly, Sanofi, Novartis, Merck

May 18, 2026 10:59AM Trump to unveil more discounted prescription drug options - CNBC

May 18, 2026 06:46AM Merck endometrial cancer drug meets survival goals in phase 3 trial

May 12, 2026 06:45AM Merck to present oncology data across 25 cancer types at ASCO 2026

May 7, 2026 02:12PM Merck publishes synthesis method for oral PCSK9 inhibitor in Science

May 6, 2026 05:01AM Citi Reinstates Merck (MRK) at Neutral

Apr 30, 2026 06:32AM Merck (MRK) Tops Q1 EPS by 20c; offers guidance

Apr 29, 2026 11:21AM Merck (MRK) call put ratio 1.4 calls to 1 put into quarter results

Apr 29, 2026 04:41AM Merck (MRK) call put ratio 1 call to 1.4 puts into quarter results

Apr 27, 2026 06:42AM Guggenheim Reiterates Buy Rating on Merck (MRK)

Apr 25, 2026 04:00AM AI is starting to impact the pharma sector — These 2 stocks are seen as NT winners

Apr 22, 2026 08:01AM Merck and Google Cloud announce $1 billion AI partnership

Apr 20, 2026 09:51AM UBS Reiterates Buy Rating on Merck (MRK)

Apr 17, 2026 07:50AM European Commission approves Merck's ENFLONSIA for RSV prevention in infants

Apr 14, 2026 10:35AM Amazon cloud unit launches AI tool to accelerate drug discovery

Apr 13, 2026 09:49AM Merck (MRK) PT Raised to $145 at UBS

Apr 13, 2026 07:01AM FDA grants priority review to ifinatamab deruxtecan for lung cancer treatment

Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

Apr 9, 2026 07:09AM Guggenheim Reiterates Buy Rating on Merck (MRK)

Apr 8, 2026 07:59AM Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald As '26 Catalysts Already Credited

Apr 7, 2026 09:04AM Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share

Mar 30, 2026 04:31PM Truist Securities Downgrades Terns Pharmaceuticals (TERN) to Hold

Mar 30, 2026 04:11PM Merck (MRK) PT Raised to $138 at Jefferies

Mar 30, 2026 11:45AM Merck drug shows superior cholesterol reduction in phase 3 trial

Mar 30, 2026 09:32AM Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald After Ph 2 CADENCE Data Release

Mar 27, 2026 08:50AM Mizuho Downgrades Terns Pharmaceuticals (TERN) to Neutral on Merck acquisition

Mar 26, 2026 06:57AM Guggenheim Reiterates Buy Rating on Merck (MRK)

Mar 25, 2026 04:09PM TD Cowen Downgrades Terns Pharmaceuticals (TERN) to Hold

Mar 25, 2026 12:24PM BofA Securities on Merck (MRK): Terns adds to 2025 deals for de-risked drugs 'with growth expected during Keytrude LOE period'

Mar 25, 2026 10:30AM Morgan Stanley on Merck (MRK): Terns acquisition 'encouraging and consistent with prior commentary'

Mar 25, 2026 10:13AM H.C. Wainwright Downgrades Terns Pharmaceuticals (TERN) to Neutral

Mar 25, 2026 09:34AM Barclays on Merck (MRK): Terns deal shows Merck shifting toward 'more diversified onco strategy'

Mar 25, 2026 08:12AM Truist Securities stays Buy on Terns Pharmaceuticals (TERN) as Merck acquires 'for a steal'

View Older Stories